Page last updated: 2024-08-23

etoposide and Arterial Diseases, Carotid

etoposide has been researched along with Arterial Diseases, Carotid in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Altena, R; Boer, H; Boezen, HM; Dijck-Brouwer, DAJ; Gietema, JA; Kema, IP; Klont, F; Lefrandt, JD; Meijer, C; Nuver, J; Smit, AJ; van Faassen, M; Westerink, NL; Zwart, N	1
Buchbinder, D; Casillas, J; Linetsky, M; Steinberg, G	1

Other Studies

2 other study(ies) available for etoposide and Arterial Diseases, Carotid

Article	Year
Single-nucleotide polymorphism in the 5-α-reductase gene (SRD5A2) is associated with increased prevalence of metabolic syndrome in chemotherapy-treated testicular cancer survivors. European journal of cancer (Oxford, England : 1990), 2016, Volume: 54 Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Adolescent; Adult; Albuminuria; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Carotid Artery Diseases; Cisplatin; Cross-Sectional Studies; Etoposide; Gene Frequency; Heterozygote; Homozygote; Humans; Male; Membrane Proteins; Metabolic Syndrome; Middle Aged; Netherlands; Phenotype; Polymorphism, Single Nucleotide; Prevalence; Risk Factors; Survivors; Testicular Neoplasms; Testosterone; Time Factors; Treatment Outcome; Young Adult	2016
Moyamoya in a child treated with interferon for recurrent osteosarcoma. Journal of pediatric hematology/oncology, 2010, Volume: 32, Issue:6 Topics: Antineoplastic Agents; Bone Neoplasms; Carotid Artery Diseases; Cerebral Arterial Diseases; Cerebral Infarction; Chemotherapy, Adjuvant; Child; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Interferon-alpha; Lung Neoplasms; Magnetic Resonance Angiography; Methotrexate; Moyamoya Disease; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Osteosarcoma; Thyroiditis, Autoimmune	2010

Article

Year

Single-nucleotide polymorphism in the 5-α-reductase gene (SRD5A2) is associated with increased prevalence of metabolic syndrome in chemotherapy-treated testicular cancer survivors.

European journal of cancer (Oxford, England : 1990), 2016, Volume: 54

Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Adolescent; Adult; Albuminuria; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Carotid Artery Diseases; Cisplatin; Cross-Sectional Studies; Etoposide; Gene Frequency; Heterozygote; Homozygote; Humans; Male; Membrane Proteins; Metabolic Syndrome; Middle Aged; Netherlands; Phenotype; Polymorphism, Single Nucleotide; Prevalence; Risk Factors; Survivors; Testicular Neoplasms; Testosterone; Time Factors; Treatment Outcome; Young Adult

2016

Moyamoya in a child treated with interferon for recurrent osteosarcoma.

Journal of pediatric hematology/oncology, 2010, Volume: 32, Issue:6

Topics: Antineoplastic Agents; Bone Neoplasms; Carotid Artery Diseases; Cerebral Arterial Diseases; Cerebral Infarction; Chemotherapy, Adjuvant; Child; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Interferon-alpha; Lung Neoplasms; Magnetic Resonance Angiography; Methotrexate; Moyamoya Disease; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Osteosarcoma; Thyroiditis, Autoimmune

2010